Join us in bringing the Gordon F. Derner Institute of Advanced Psychological Studies family together on a day to celebrate psychology and our community, while teaching current and future students what the Institute offers.
At the event, we will hear from keynote speaker Dr. Jermaine Jones, Assistant Professor of Clinical Neuroscience in the Department of Psychiatry at the College of Physicians and Surgeons of Columbia University, whose research focuses on identifying genetic risk factors for opioid abuse in addition to testing pharmacotherapies to inhibit opioid action. The event will also feature a faculty panel discussion on “Hot Topics” in Psychology as they relate to addictions, a breakout student discussion led by Adelphi students, and a roundtable discussion with Derner alumni about career opportunities in psychology.
SCHEDULE OF EVENTS
|9:00 a.m.–11:00 a.m.||Internship Program Breakfast Event|
|11:00 a.m.–12:50 p.m.||Brunch and “Hot Topics” Faculty Panel Discussion|
|1:00 p.m.–2:15 p.m.||Keynote Speaker, Dr. Jermaine Jones, Ph.D., Assistant Professor of Clinical Neuroscience in the Department of Psychiatry at the College of Physicians and Surgeons of Columbia University|
|2:25 p.m.–3:40 p.m.||Student-led discussion: This is your TV on Drugs|
|3:45 p.m.–4:30 p.m.||Career Opportunities round-table with Alumni and Dessert Reception|
Jermaine Jones, Ph.D. is Assistant Professor of Clinical Neuroscience in the Department of Psychiatry at the College of Physicians & Surgeons at Columbia University.
Dr. Jones leads multiple research projects at the New York State Psychiatric Institute. His work focuses on both the genetic risk factors increasing vulnerability to opioid abuse and the action of novel pharmacological agents that may reduce opioid abuse. A novel aspect of Dr. Jones’ work is his utilization of human laboratory models, where research participants reside in a laboratory for an extended period of time while they are observed by research personnel.
Prior to his work at Columbia University, Dr. Jones received his Ph.D. in Experimental Psychology with the Psychopharmacology Laboratory at American University. At American University, he investigated how a monoamine transporter led to the aversive subjective effects of cocaine use through pharmacological and transgenic methodologies. Dr. Jones then completed his postdoctoral training with Columbia’s Division on Substance Abuse, where he studied behavioral pharmacology of opioids in clinical populations under Dr. Sandra Comer. Since his doctoral education, Dr. Jones has been interested in the biological and behavioral mechanisms of addiction.
Gordon F. Derner Institute of Advanced Psychological Studies
p – 516.877.4800